Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

N/ANon-phased studies

6(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Other(2)

Detailed Status

Recruiting3

unknown2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A6 (100.0%)

Trials by Status

recruiting350%

unknown233%

completed117%

Recent Activity

3 active trials

Showing 5 of 6

recruitingnot_applicable

40Hz tACS in Treating Cognitive Function and Modulating Neurophysiology of Patients With Alzheimer's Disease

NCT05723172

completednot_applicable

tACS Improves Memory in Elders With Subjective Memory Complaints

NCT05569902

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT05923606Not Applicable

Modulation of Brain Oscillations Underlying Working Memory

Recruiting

NCT03036319Not Applicable

Patient-Centered NeuroRehabilitation (PCN)

Recruiting

NCT06891326Not Applicable

Efficacy and Safety of tACS for Depression: a Multicenter RCT Study

Recruiting

NCT05723172Not Applicable

40Hz tACS in Treating Cognitive Function and Modulating Neurophysiology of Patients With Alzheimer's Disease

Unknown

NCT05569902Not Applicable

tACS Improves Memory in Elders With Subjective Memory Complaints

Completed

NCT03756610Not Applicable

Transcranial Alternating Current Stimulation (tACS) for Cognitive Impairments in Patients With Schizophrenia

Unknown

All 6 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 6